Shilanski & Associates, Inc. Pfizer Inc Transaction History

Shilanski & Associates, Inc.

$296 Million
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$25.89 - $29.73 $71,715 - $82,352	2,770 Added 2.97%	95,965 $2.66 Million
Q4 2023 Jan 09, 2024	BUY	$26.13 - $33.94 $19,623 - $25,488	751 Added 0.81%	93,195 $2.68 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $93,317 - $109,079	2,908 Added 3.25%	92,444 $3.07 Million
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $87,952 - $101,758	2,435 Added 2.8%	89,536 $3.28 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $84,846 - $110,457	2,154 Added 2.54%	87,101 $3.55 Million
Q4 2022 Jan 30, 2023	BUY	$41.75 - $54.5 $3.25 Million - $4.25 Million	77,892 Added 1104.07%	84,947 $4.35 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $3.24 Million - $3.96 Million	-74,057 Reduced 91.3%	7,055 $309,000
Q2 2022 Aug 02, 2022	BUY	$46.53 - $55.17 $72,261 - $85,679	1,553 Added 1.95%	81,112 $4.25 Million
Q1 2022 Apr 20, 2022	SELL	$45.75 - $56.69 $76,539 - $94,842	-1,673 Reduced 2.06%	79,559 $4.12 Million
Q4 2021 Jan 12, 2022	SELL	$41.32 - $61.25 $94,953 - $140,752	-2,298 Reduced 2.75%	81,232 $4.8 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $82,268 - $105,680	2,096 Added 2.57%	83,530 $3.59 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $71,676 - $81,197	1,996 Added 2.51%	81,434 $3.19 Million
Q1 2021 Apr 14, 2021	SELL	$33.49 - $37.77 $224,851 - $253,587	-6,714 Reduced 7.79%	79,438 $2.88 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $56,129 - $71,373	1,677 Added 1.99%	86,152 $3.17 Million
Q3 2020 Nov 12, 2020	SELL	$31.75 - $37.25 $1,809 - $2,123	-57 Reduced 0.07%	84,475 $3.1 Million
Q2 2020 Jul 31, 2020	BUY	$30.12 - $36.54 $71,685 - $86,965	2,380 Added 2.9%	84,532 $2.76 Million
Q1 2020 Apr 14, 2020	BUY	$27.03 - $38.62 $76,684 - $109,564	2,837 Added 3.58%	82,152 $2.68 Million
Q4 2019 Jan 30, 2020	BUY	$32.92 - $37.36 $29,595 - $33,586	899 Added 1.15%	79,315 $3.11 Million
Q3 2019 Oct 25, 2019	BUY	$32.49 - $42.13 $64,265 - $83,333	1,978 Added 2.59%	78,416 $2.82 Million
Q2 2019 Aug 05, 2019	BUY	$36.98 - $41.52 $2.83 Million - $3.17 Million	76,438 New	76,438 $3.31 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.7 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.73 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.46 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shilanski & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Shilanski & Associates, Inc. with notifications on news.

Account